Clinical & epidemiological profile of malignancy in HIV a retrospective study
Abstract
Background: HIV is the etiologic agent of AIDS. HIV infection is associated with various types of opportunistic infections and malignancies. The incidence of malignancies among Human Immunodeficiency Virus (HIV) infected patients is known to be higher than in the general population. The study was aimed to know the profile of malignancy in HIV infected individuals.
Methodology: Study was a Retrospective study & data was collected from medical records department using semi structured proforma. 40 HIV subjects diagnosed with malignancy was obtained. Stastical analysis of data was done using Chi square test and Fisher’s exact test.
Results: Out of 40 HIV subjects diagnosed with malignancy in our study 62%, were males and 38% were females, 95% were receiving ART, Predominantly the patients were in STAGE 4 and NHL was the most common malignancy in our study. CD4 count has no correlation with the incidence of malignancy.
Conclusion: Age and Gender distribution does not affect the type of malignancy. Non AIDS defining malignancies are more prevalent than AIDS defining malignancies. NHL is the commonest type of AIDS defining malignancy. CD4 count and HIV stage does not predict the type of malignancy, immunodeficiency can be a trigger for development of malignancy.
Downloads
References
2. Spano JP, Atlan D, Breau JL, Farge D. AIDS and non-AIDS-related malignancies: a new vexing challenge in HIV-positive patients. Part I: Kaposi'ssarcoma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma. Eur J Intern Med. 2002 May;13(3):170-79.
3. Frisch M, Biggar RJ, Engels EA, Goedart JJ. Association of Cancer with AIDS related immunosuppression in adults. JAMA. 2001Apr 4;285(13):1736-45. [PubMed]
4. International collaboration on HIV and Cancer. Highly active anti-retroviral therapy and incidence of cancer in Human Immuno Deficiency Virus – Infected Adults. J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.
5. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS – associated malignant disorders. Lancet. 1998 Jun 20;351(9119):1833-9. [PubMed]
6. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):527-33. [PubMed]
7. Dhir AA, Sawant SP. Malignancies in HIV: the Indian scenario. Curr Opin Oncol. 2008 Sep;20(5):517-21. doi: 10.1097/CCO.0b013e32830a4c87. [PubMed]
8. Chitale AR. Cancer and AIDS. Indian J Pathol Microbiol. 2005 Apr;48(2):151-60. [PubMed]
9. Lanjewar DN, Duggal R. Pulmonary pathology in patients with AIDS: An autopsy study from Mumbai. HIV Med. 2001 Oct;2(4):266-71. [PubMed]
10. Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, GanesanA et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009 Jan 2;23(1):41-50. doi: 10.1097/QAD.0b013e328317cc2d. [PubMed]
11. Venkatesh KK, Saghayam S, Devaleenal B et al, Spectrum of malignancies among HIV infected patients in south India, Indian J Cancer 2012 Jan-Mar;49(1):176-80. [PubMed]
12. Uday A Phatak, Ravindra Joshi et al, AIDS associated cancer an emerging challenge. JAPI 2010; Mar;58(3): 159-62. [PubMed]
13. M.C. F. Prosperi, A. Cozzi-Lepri, A. Castagna et al, Incidence of malignancies in HIV infected patients and prognostic role of current CD4 cell count evidence from a large Italian Cohort study, CID 2010;50(9):1316-21. [PubMed]
14. Shiels MS, Pfeiffer RM, Gail MH et al, Cancer burden in HIV infected population in the united states, JNCI 2011 May 4;103(9):753-62. [PubMed]
15. Silverberg MJ, Abrams DI. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? CurrOpin HIV AIDS 2009; 4(1):42–51.
OAI - Open Archives Initiative
